The results indicated that tumor size, lymph node metastasis, pTNM stage, cIAP1 expression, and cIAP1+/ cIAP2+ were good predictors of OS for NSCLC patients (Table 4). The gene discussed is BIRC2; the disease is non-small cell lung carcinoma.